Concord Biotech listing: Rakesh Jhunjhunwala-backed company makes stellar debut at bourses

Concord Biotech debuted at a healthy premium of 21% on the exchanges on Friday. The stock listed at Rs 900 on NSE and BSE over the IPO price of Rs 741 apiece, a premium of Rs 159 as against the issue price. Meanwhile, the stock further rallied 9.7% to Rs 987 in Friday's intraday trade, taking the total gains to over 33%.
► Subscribe to The Economic Times for the latest video updates. It's free! - https://www.youtube.com/TheEconomicTi...

► More Videos @ ETTV - https://economictimes.indiatimes.com/TV

► https://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/Economi...

Follow ET on:

► Facebook -   / economictimes  
► Twitter -   / economictimes  
► LinkedIn -   / economictimes  
► Instagram -   / the_economic_times  
► Flipboard - https://flipboard.com/@economictimes

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews